查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1792654

視網膜手術設備市場規模、佔有率、趨勢及預測（按設備類型、應用、最終用途和地區），2025 年至 2033 年

Retinal Surgery Devices Market Size, Share, Trends and Forecast by Equipment Type, Application, End-Use, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球視網膜手術設備市場規模為 22 億美元。展望未來， IMARC Group估計，到 2033 年，市場規模將達到 39 億美元，2025-2033 年期間的複合年成長率為 6.3%。北美目前佔據市場主導地位，到 2024 年將佔據約 35% 的顯著市場。隨著人口老化和糖尿病病例增加，糖尿病視網膜病變和 AMD 等視網膜疾病的盛行率不斷上升，推動了市場的發展。微創手術（如微切口玻璃體切除術）的技術進步提高了治療效果。不斷成長的醫療保健支出、新興市場眼部保健服務的改善以及政府促進早期診斷的舉措進一步推動了需求。此外，不斷增加的研發投入和創新設備的引進正在進一步擴大視網膜手術設備的市場佔有率。

市場受到老年黃斑部病變 (AMD)、糖尿病視網膜病變和視網膜剝離等視網膜疾病盛行率上升的推動。微創手術技術（例如微切口玻璃體切除術 (MIVS)）的技術進步提高了治療效果和患者預後。此外，老年人口的成長更容易罹患視網膜疾病，這也刺激了市場需求。到 2080 年，全球 65 歲及以上人口預計將達到 22 億，超過 18 歲以下兒童的數量，而 2080 年代全球人口峰值為 103 億。預期壽命也在增加，從 2024 年的 73.3 歲增加到 2054 年的 77.4 歲，導致老年人口對眼保健服務的需求增加。老年人口結構的變化表明，迫切需要投資尖端視網膜手術技術，以改善全球快速成長的老年市場的視力健康。新興經濟體醫療保健支出的增加和先進眼科護理服務可近性的改善，進一步促進了視網膜手術設備市場的成長。政府的支持性措施以及人們對早期診斷和治療意識的提高，也對市場擴張發揮重要作用。

美國是一個重要的區域市場，主要原因是慢性眼疾發生率不斷上升，尤其是在老年人口中。超過 1,200 萬 40 歲及以上的美國成年人患有視力障礙，其中包括 100 萬人失明。預計到 2050 年，這一數字將增加一倍以上，主要原因是衰老和糖尿病等慢性疾病。視力障礙是美國成年人十大健康問題之一，其中 90% 的可預防失明病例是由糖尿病視網膜病變引起的。由於到 2050 年，視力障礙的經濟成本可能達到 3,730 億美元，因此對治療此類無法避免的疾病的創新視網膜手術設備的需求很高。糖尿病病例的增加導致對糖尿病視網膜病變治療的需求增加，而玻璃體切除系統和手術雷射的創新改善了手術效果。強大的醫療基礎設施和主要行業參與者的存在推動了先進技術的快速應用。此外，患者意識的提高和主動篩檢計劃有助於早期發現疾病，從而改善手術干預。新設備的監管批准和製造商之間的策略合作進一步刺激了市場擴張，確保了尖端視網膜手術解決方案的穩定供應。

視網膜手術設備市場趨勢：

眼部疾病盛行率上升

在全球範圍內，視力相關疾病在人群中的盛行率不斷上升，這是市場成長的主要催化劑。黃斑部病變、視網膜色素變性和糖尿病視網膜病變等疾病正變得越來越普遍，尤其是在全球糖尿病患者和老年人口中。此外，光是糖尿病視網膜病變就影響了全球25.2%的糖尿病患者，其中第1型糖尿病患者的發生率（約75%）顯著高於第2型糖尿病患者的50%。根據視網膜手術設備市場預測，這些令人擔憂的統計數據正在推動對有效且高效的手術解決方案的需求。需要精準治療的病例數量的增加，導致視網膜手術設備的採用率不斷提高，這些設備被認為具有成本效益高、省時省力、手術效率高的特點。隨著全球糖尿病人口的成長，預計這一趨勢將持續下去，從而支持市場擴張。為此，醫療保健提供者優先考慮早期診斷和先進的手術干預，以有效管理漸進性眼部疾病。

老年人口和年齡相關性視力喪失

全球人口老化是另一個顯著因素，推動了視網膜手術設備市場的需求。老年人更容易患上與年齡相關的眼部疾病，例如白內障、青光眼和老花眼。白內障的盛行率就是一個明顯的例子：在45-54歲的人群中，女性盛行率為4%，男性盛行率為2.4%，而75歲以上男性盛行率則大幅上升至30.49%和27.97%。隨著全球人口老化，醫療保健產業對老年患者獨特需求的先進手術干預措施的需求也隨之成長。視網膜手術設備具有顯著的優勢，包括疼痛減輕、疤痕減少和恢復時間更快，對老年患者尤其具有吸引力。老年患者越來越容易患上慢性視力問題，促使醫療保健系統和設備製造商投資於能夠改善治療效果，同時確保老年人舒適和安全的技術。因此，這進一步創造了一個積極的視網膜手術設備市場前景。

技術進步和糖尿病發生率上升

微創手術工具和設備的技術進步正在極大地塑造視網膜手術設備市場的未來。同時，全球糖尿病病例的急劇增加也進一步催生了對專業眼科護理解決方案的需求。根據國際糖尿病聯盟 (IDF) 的數據，目前全球近 5.89 億成年人患有糖尿病，預計到 2050 年將上升到 8.53 億。這種慢性疾病每年導致超過 340 萬人死亡，是糖尿病視網膜病變和相關視力問題病例增加的主要原因。向微創手術的轉變符合人們對更好的患者治療效果、更快的康復和更強的安全性的更廣泛追求。視網膜手術設備的創新在提供這些益處的同時，也滿足了日益成長的糖尿病族群的獨特醫療需求。隨著全球對治療方案的認知不斷傳播，技術創新與健康人口統計的融合正在推動市場成長。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球視網膜手術設備市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依設備類型

  • 玻璃體切除機
  • 視網膜雷射設備
  • 手術器械
    • 主要類型
      • 套管
      • 鉗子
      • 切刀
      • 冷凍探針
      • 其他

第7章：市場區隔：依應用

  • 糖尿病視網膜病變
  • 視網膜剝離
  • 其他

第 8 章：市場區隔：最終用途別

  • 醫院
  • 眼科診所
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格指標

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Alcon Management SA
    • Bausch & Lomb Incorporated
    • Carl Zeiss
    • Ellex Medical Lasers
    • Erbe Elektromedizin
    • Escalon Medicals
    • Iridex Corporation
    • Leica Microsystems GmbH
    • Lumenis
    • Nidek Co. Ltd.
    • Optos PLC
    • Second Sigh Medical Products
    • Synergetics USA Inc.
    • Topcon Corporation
Product Code: SR112025A2059

The global retinal surgery devices market size was valued at USD 2.2 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 3.9 Billion by 2033, exhibiting a CAGR of 6.3% during 2025-2033. North America currently dominates the market, holding a significant market share of around 35% in 2024. The market is driven by the rising prevalence of retinal disorders, including diabetic retinopathy and AMD, fueled by aging population and increasing diabetes cases. Technological advancements in minimally invasive surgeries, such as microincision vitrectomy, enhance treatment efficacy. Growing healthcare expenditure, improved access to eye care in emerging markets, and government initiatives promoting early diagnosis further propel demand. Additionally, increasing R&D investments and the introduction of innovative devices are further expanding the retinal surgery devices market share.

The market is driven by the rising prevalence of retinal disorders such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal detachment. Technological advancements in minimally invasive surgical techniques, such as microincision vitrectomy surgery (MIVS), enhance treatment efficacy and patient outcomes. Additionally, the growing geriatric population, which is more susceptible to retinal diseases, fuels market demand. By 2080, the global number of individuals aged 65 and above is expected to stand at 2.2 billion, outnumbering children under the age of 18, against a background of a peak global population of 10.3 billion in the 2080s. Life expectancy is also increasing, rising from 73.3 years in 2024 to 77.4 years in 2054, resulting in increased demand for eye care services among the elderly population. The changing demographics of the aging population indicate the urgent need for investment in cutting-edge retinal surgery technologies to improve vision health in the fast-growing geriatric markets around the world. Increased healthcare expenditure and improved access to advanced ophthalmic care in emerging economies further contribute to the retinal surgery devices market growth. Supportive government initiatives and increasing awareness about early diagnosis and treatment also play a significant role in expanding the market.

The United States stands out as a key regional market, primarily driven by the rising incidences of chronic eye conditions, particularly among the aging population. Over 12 million U.S. adults aged 40 and older have vision impairment, including 1 million who are blind. The number is estimated to more than double by the year 2050, mostly due to aging and chronic conditions such as diabetes. Vision disability ranks among the leading ten health problems in U.S. adults, with diabetic retinopathy causing 90% of cases of preventable blindness. Since the economic cost of vision impairment is likely to hit USD 373 Billion by 2050, demand for innovative retinal surgery equipment to treat such inescapable disorders is high. Increasing cases of diabetes contribute to higher demand for diabetic retinopathy treatments, while innovations in vitrectomy systems and surgical lasers improve procedural outcomes. Strong healthcare infrastructure and the presence of major industry players drive rapid adoption of advanced technologies. Additionally, heightened patient awareness and proactive screening programs facilitate early disease detection, improving surgical interventions. Regulatory approvals for novel devices and strategic collaborations among manufacturers further stimulate market expansion, ensuring a steady pipeline of cutting-edge retinal surgical solutions.

Retinal Surgery Devices Market Trends:

Rising Eye Disorder Prevalence

The increasing global prevalence of vision-related disorders among the masses is a major catalyst for growth in the market. Conditions such as macular degeneration, retinitis pigmentosa, and diabetic retinopathy are becoming more widespread, especially among diabetic and aging populations across the globe. Along with this, diabetic retinopathy alone affects 25.2% of individuals living with diabetes worldwide, with a significantly higher occurrence in type 1 diabetics (approximately 75%) compared to 50% in type 2 diabetics. According to the retinal surgery devices market forecast, these alarming statistics are pushing the demand for effective and efficient surgical solutions. The rise in cases requiring precise treatment is leading to increased adoption of retinal surgery devices, which are considered cost-effective, time-saving, and highly efficient during procedures. With a growing global diabetic population, this trend is expected to persist, supporting market expansion. In response, healthcare providers are prioritizing early diagnosis and advanced surgical interventions to manage progressive eye diseases effectively.

Geriatric Population and Age-Related Vision Loss

The aging demographic worldwide is another prominent factor enhancing the retinal surgery devices market demand. Elderly individuals are more susceptible to age-related ocular diseases such as cataracts, glaucoma, and presbyopia. Cataract prevalence provides a clear example: among individuals aged 45-54, the condition affects 4% of females and 2.4% of males, which dramatically increases to 30.49% in females and 27.97% in males aged 75 and above. As the global population continues to age, the healthcare sector is experiencing a corresponding rise in the need for advanced surgical interventions tailored to the unique requirements of older patients. Retinal surgery devices offer significant benefits, including less pain, minimal scarring, and quicker recovery times, which are particularly appealing for geriatric patients. This demography's growing vulnerability to chronic vision issues is encouraging healthcare systems and device manufacturers to invest in technologies that improve outcomes while ensuring comfort and safety for older individuals. Therefore, this is further creating a positive retinal surgery devices market outlook.

Technological Advancements and Rising Diabetes Incidence

Technological progress in minimally invasive surgical tools and equipment is significantly shaping the future of the retinal surgery devices market. Simultaneously, the steep rise in global diabetes cases is creating further demand for specialized eye care solutions. According to the International Diabetes Federation (IDF), nearly 589 million adults currently live with diabetes, a number projected to rise to 853 million by 2050. This chronic condition contributes to more than 3.4 million deaths each year and is a key driver behind the increasing cases of diabetic retinopathy and related vision issues. The shift towards minimally invasive surgeries aligns with the broader push for better patient outcomes, faster recovery, and enhanced safety. Innovations in retinal surgery devices are offering these benefits while catering to the growing diabetic population's unique medical needs. As awareness of treatment options spreads globally, this convergence of technological innovation and health demographics is propelling market growth.

Retinal Surgery Devices Industry Segmentation:

Analysis by Equipment Type:

  • Vitrectomy Machines
  • Retinal Laser Equipment
  • Surgical Instruments
    • Cannulas
    • Forceps
    • Cutters
    • Cryoprobes
    • Others

Vitrectomy machines stand as the largest component in 2024, holding around 44.8% of the market, driven by their critical role in treating complex retinal conditions, such as diabetic retinopathy, retinal detachment, and macular holes. These advanced systems enable precise removal of vitreous gel and scar tissue while minimizing trauma to surrounding structures, improving surgical outcomes. According to the retinal surgery devices market research report, the shift toward minimally invasive vitrectomy surgery (MIVS) with smaller-gauge instruments has further increased adoption, reducing recovery times and complications. Technological advancements, including high-speed cutters, integrated fluidics, and enhanced visualization systems, enhance surgical efficiency and safety. Additionally, the rising prevalence of retinal diseases, an aging population, and increasing diabetic cases contribute to sustained demand. Leading manufacturers continue to innovate, introducing portable and user-friendly systems that expand accessibility in both hospitals and ambulatory surgical centers. With superior efficacy and expanding applications, vitrectomy machines remain indispensable in retinal surgery, securing their position as the leading equipment type in the market.

Analysis by Application:

  • Diabetic Retinopathy
  • Retinal Detachment
  • Others

Diabetic retinopathy leads the market with around 40.6% of market share in 2024, primarily due to the escalating global prevalence of diabetes and its associated ocular complications. As a leading cause of vision loss among working-age adults, this progressive condition demands advanced surgical interventions such as vitrectomy and laser photocoagulation to manage vitreous hemorrhages, retinal detachment, and macular edema. The growing diabetic population, coupled with poor glycemic control in many patients, fuels the need for early and aggressive treatment, driving demand for specialized retinal surgery devices. Additionally, increasing awareness about diabetes-related eye complications and improved screening programs have led to earlier diagnosis, expanding the patient pool requiring surgical care. Technological advancements in imaging and microsurgical tools further enhance treatment precision, supporting segment growth. With diabetes rates continuing to rise worldwide, particularly in aging populations, diabetic retinopathy is expected to maintain its dominance as the key application driving the retinal surgery devices market.

Analysis by End-Use:

  • Hospitals
  • Ophthalmology Clinics
  • Others

Hospitals lead the market with around 60.1% of market share in 2024, due to their advanced infrastructure, availability of skilled ophthalmologists, and ability to handle complex retinal procedures. Equipped with state-of-the-art operating rooms and diagnostic tools, hospitals are the primary settings for vitrectomies, retinal detachment repairs, and other intricate eye surgeries. The increasing prevalence of retinal disorders, coupled with rising hospital admissions for vision-related conditions, further drives demand in this segment. Additionally, hospitals often serve as referral centers for specialized ophthalmic care, attracting patients requiring advanced surgical interventions. The growing adoption of minimally invasive retinal surgeries in hospital settings, supported by favorable reimbursement policies, also contributes to segment dominance. With continuous investments in healthcare infrastructure and the integration of cutting-edge surgical technologies, hospitals remain the preferred choice for retinal treatments, reinforcing their position as the leading end-use segment in the market.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 35%, driven by advanced healthcare infrastructure, high adoption of innovative surgical technologies, and a significant patient pool suffering from retinal disorders. The region's leadership is reinforced by the rising prevalence of diabetes and age-related macular degeneration (AMD), increasing demand for vitrectomy and other retinal procedures. Well-established reimbursement policies, particularly in the U.S., enhance patient access to advanced treatments, while strong R&D investments by key industry players accelerate product development. Additionally, the presence of leading ophthalmic centers and skilled surgeons supports the adoption of cutting-edge devices. High awareness about retinal health and proactive screening programs further contribute to early diagnosis and surgical intervention. With continuous technological advancements and favorable regulatory frameworks, North America remains the largest and most influential regional segment in the global retinal surgery devices market.

Key Regional Takeaways:

United States Retinal Surgery Devices Market Analysis

In 2024, the US accounted for around 85.80% of the total North America retinal surgery devices market. The United States market is primarily driven by the increasing prevalence of retinal disorders, including age-related macular degeneration (AMD) and diabetic retinopathy. According to the CDC, in 2021, approximately 9.6 million individuals in the United States were affected by diabetic retinopathy (DR). Among them, 1.84 million were experiencing vision-threatening forms of DR. In line with this, continual advancements in retinal imaging and diagnostic technologies, enabling earlier detection and more accurate treatment of retinal conditions, are propelling market growth. Furthermore, the rising aging population, which is more susceptible to retinal diseases, is contributing to market demand. Additionally, the growing adoption of minimally invasive procedures, with these techniques offering quicker recovery times and reduced risks, is driving the market expansion. The enhanced surgical outcomes facilitated by innovations in retinal surgery devices, such as improved lasers and surgical microscopes, are stimulating market appeal. Similarly, the increased awareness of retinal diseases and advancements in personalized medicine are expanding the market scope. Moreover, favorable reimbursement policies and government initiatives promoting eye health are creating lucrative opportunities in the market.

Europe Retinal Surgery Devices Market Analysis

The market in Europe is experiencing growth due to increasing geriatric population leading to a higher prevalence of age-related macular degeneration and diabetic retinopathy. As per an industry report, in Europe, age-related macular degeneration (AMD) affects about 67 million individuals, projected to reach 77 million by 2050. Prevalence rises from 5% in ages 55-64 to 17.4% in those over 85, with 1.4 late-stage AMD cases per 1,000 individuals aged 60+, annually. Similarly, enhanced reimbursement policies in key European countries are making retinal procedures more accessible in the market. The growing adoption of minimally invasive vitreoretinal surgery techniques fueling the need for precision instruments, is fostering market expansion. Furthermore, continuous innovation by European manufacturers in micro-incision and illumination technologies is accelerating higher product uptake. The rising awareness campaigns and proactive screening initiatives improving early diagnosis rates are enhancing market appeal. Additionally, the expansion of ophthalmology training programs contributing to a skilled workforce, enabling the safe use of complex devices, is bolstering market development. Besides this, numerous cross-border healthcare collaborations and harmonized regulatory frameworks within the EU encouraging product approvals and regional distribution, are providing an impetus to the market.

Asia Pacific Retinal Surgery Devices Market Analysis

The Asia Pacific market is being propelled by the changing lifestyles, rising diabetes rates, and increasing diabetic retinopathy cases. According to NCBI, the number of individuals with diabetes in India rose sharply from 33 million in 2000 to 72 million in 2021 and is expected to reach 125 million by 2045. In accordance with this, rising investments in public and private healthcare infrastructure, improving access to advanced ophthalmic procedures, are supporting market expansion. The increasing presence of a large patient pool and rising disposable incomes is increasing the affordability and demand in the market. Furthermore, the expansion of medical tourism across Southeast Asia, heightening the requirement for cutting-edge retinal surgical technologies, is a significant market driver. Additionally, the growing presence of device makers in the region, augmenting access to innovative retinal surgery tools suited to local needs, is impelling the market. Moreover, favorable government-led health initiatives in countries including India and China, promoting eye health awareness and early detection, are impacting the market dynamics.

Latin America Retinal Surgery Devices Market Analysis

In Latin America, the market is advancing due to increasing rates of chronic eye conditions such as retinal detachment and macular holes, particularly in aging populations. Furthermore, various government-led efforts to expand universal healthcare coverage are enhancing access to ophthalmic surgeries in the market. As per NCBI, 14.14% of the population in Latin America suffers from moderate to severe vision impairment and blindness. Blindness is most prevalent in Tropical Latin America at 3.89%, and least in Southern Latin America at 0.96%. The rising awareness about preventable blindness fostering early diagnosis and timely interventions, is propelling the market growth. In addition to this, numerous regional partnerships with global manufacturers are driving advanced surgical tech and training adoption, augmenting outcomes in public and private care.

Middle East and Africa Retinal Surgery Devices Market Analysis

The market in the Middle East and Africa is significantly progressing attributed to the growing burden of inherited retinal disorders. Similarly, increasing penetration of vision care services in underserved rural areas, expanding the treatment base, is impelling development in the market. Furthermore, the rising prevalence of hypertension and lifestyle-related conditions is leading to a rise in retinal vascular complications is driving the need for precision retinal surgery tools and advanced diagnostic equipment, thereby expanding market reach. According to NCBI, hypertension affects approximately 36% of the general population in the African region. Apart from this, strategic collaborations with international ophthalmic organizations, enhancing clinical training and knowledge transfer, are influencing the market dynamics.

Competitive Landscape:

The competitive landscape of the market is characterized by intense rivalry among key players striving to strengthen their market position. Companies are focusing on technological advancements, launching next-generation devices with enhanced precision, efficiency, and minimally invasive capabilities. Strategic collaborations, mergers, and acquisitions are common as firms aim to expand their product portfolios and geographic reach. Investments in research and development are prioritized to introduce innovative solutions for complex retinal conditions. Additionally, players are emphasizing regulatory approvals and clinical validations to ensure product efficacy and safety. Marketing strategies include educational initiatives to raise awareness among healthcare professionals, while competitive pricing and after-sales support further drive adoption. The market also sees a growing emphasis on portable and user-friendly systems to cater to diverse clinical settings, reinforcing competition.

The report provides a comprehensive analysis of the competitive landscape in the retinal surgery devices market with detailed profiles of all major companies, including:

  • Alcon Management S. A.
  • Bausch & Lomb Incorporated
  • Carl Zeiss
  • Ellex Medical Lasers
  • Erbe Elektromedizin
  • Escalon Medicals
  • Iridex Corporation
  • Leica Microsystems GmbH
  • Lumenis
  • Nidek Co. Ltd.
  • Optos PLC
  • Second Sigh Medical Products
  • Synergetics USA Inc.
  • Topcon Corporation

Key Questions Answered in This Report

  • 1.How big is the retinal surgery devices market?
  • 2.What is the future outlook of the retinal surgery devices market?
  • 3.What are the key factors driving the retinal surgery devices market?
  • 4.Which region accounts for the largest retinal surgery devices market share?
  • 5.Which are the leading companies in the global retinal surgery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Retinal Surgery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Equipment Type

  • 6.1 Vitrectomy Machines
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Retinal Laser Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Surgical Instruments
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Cannulas
      • 6.3.2.2 Forceps
      • 6.3.2.3 Cutters
      • 6.3.2.4 Cryoprobes
      • 6.3.2.5 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Diabetic Retinopathy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retinal Detachment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ophthalmology Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Alcon Management S. A.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bausch & Lomb Incorporated
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Carl Zeiss
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Ellex Medical Lasers
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Erbe Elektromedizin
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Escalon Medicals
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Iridex Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Leica Microsystems GmbH
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Lumenis
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Nidek Co. Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Optos PLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Second Sigh Medical Products
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Synergetics USA Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
    • 14.3.14 Topcon Corporation
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials

List of Figures

  • Figure 1: Global: Retinal Surgery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Retinal Surgery Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Retinal Surgery Devices Market: Breakup by Equipment Type (in %), 2024
  • Figure 4: Global: Retinal Surgery Devices Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Retinal Surgery Devices Market: Breakup by End-Use (in %), 2024
  • Figure 6: Global: Retinal Surgery Devices Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Retinal Surgery Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Retinal Surgery Devices (Vitrectomy Machines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Retinal Surgery Devices (Vitrectomy Machines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Retinal Surgery Devices (Retinal Laser Equipment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Retinal Surgery Devices (Retinal Laser Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Retinal Surgery Devices (Surgical Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Retinal Surgery Devices (Surgical Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Retinal Surgery Devices (Diabetic Retinopathy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Retinal Surgery Devices (Diabetic Retinopathy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Retinal Surgery Devices (Retinal Detachment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Retinal Surgery Devices (Retinal Detachment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Retinal Surgery Devices (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Retinal Surgery Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Retinal Surgery Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Retinal Surgery Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Retinal Surgery Devices (Ophthalmology Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Retinal Surgery Devices (Ophthalmology Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Retinal Surgery Devices (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Retinal Surgery Devices (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia Pacific: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia Pacific: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Retinal Surgery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Global: Retinal Surgery Devices Industry: SWOT Analysis
  • Figure 75: Global: Retinal Surgery Devices Industry: Value Chain Analysis
  • Figure 76: Global: Retinal Surgery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Retinal Surgery Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Retinal Surgery Devices Market Forecast: Breakup by Equipment Type (in Million USD), 2025-2033
  • Table 3: Global: Retinal Surgery Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Retinal Surgery Devices Market Forecast: Breakup by End-Use (in Million USD), 2025-2033
  • Table 5: Global: Retinal Surgery Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Retinal Surgery Devices Market: Competitive Structure
  • Table 7: Global: Retinal Surgery Devices Market: Key Players